Brytly is the first over-the-counter eye drop containing apraclonidine and is approved for adults and children ages 12 and older. Medscape Medical News
Author: Medscape
AAO 2026: Accurate Diagnosis and Emerging Wet AMD Therapies
Reflections from AAO 2026 on how accurate diagnosis, individualized treatment, and emerging therapies could improve wet AMD care and reduce treatment burden. Medscape
Recognizing Cortical Visual Impairment in Children
Cortical visual impairment is the leading cause of blindness in children in the developed world and is increasing in incidence. Medscape Medical News
Varicose Veins Tied to Risk for Fluid Buildup Under Retina
Adults with varicose veins show about twice the risk for a later diagnosis of central serous chorioretinopathy, a retinal fluid disorder, a large retrospective study suggests. Medscape Medical News
Varicose Veins Tied to Risk for Fluid Buildup Under Retina
Adults with varicose veins show about twice the risk for a later diagnosis of central serous chorioretinopathy, a retinal fluid disorder, a large retrospective study suggests. Medscape Medical News
Congenital CMV: Which Infants Need an Eye Exam?
Few asymptomatic, CMV-positive newborns have signs on screening of eye abnormalities. Medscape Medical News
Study Shows Potential of Omitting Speculum in Eye Injections
A meta-analysis finds less pain with manual eyelid retraction than with a speculum and fewer complications with device-assisted techniques. Medscape Medical News
AAO 2026
Read clinically focused news coverage of key developments from AAO 2026. Medscape Ophthalmology
Can Anti-VEGF Cause More Complications in DME Patients?
A study of more than 40,000 diabetic patients found the injectable treatment associated with a nearly threefold increased risk for ocular hypertension or glaucoma over 5 years. Medscape Medical News
Switch to Faricimab May Extend Dosing Intervals in nAMD
Switching from aflibercept to faricimab is linked to longer dosing intervals and better fluid control over 3 years among patients with treatment-resistant neovascular age-related macular degeneration. Medscape Medical News
Switch to Faricimab May Extend Dosing Intervals in nAMD
Switching from aflibercept to faricimab is linked to longer dosing intervals and better fluid control over 3 years among patients with treatment-resistant neovascular age-related macular degeneration. Medscape Medical News
Drusen Type Tied to Atrophy, Not Anti-VEGF Response
A study finds drusen type is linked to macular atrophy risk in wet AMD, but not to how well eyes respond to anti-VEGF treatment. Medscape Medical News
Statins Tied to Lower Risk for Glaucoma, Fewer Procedures
Statin use is associated with a 15% lower risk of developing open-angle glaucoma at 5 years and with lower rates of laser and surgical procedures among patients already diagnosed with the condition. Medscape Medical News
Glaukos Says Late-stage Eye Disease Treatment Shows Lasting Benefits After Single Dose
Glaukos said on Wednesday patients treated with its late-stage eye disease therapy maintained improvements in vision and corneal shape three years after a single treatment… Reuters Health Information
Staying on Aspirin Seen Mostly Safe in Vitreoretinal Surgery
A meta-analysis finds staying on aspirin therapy did not necessarily raise the risk for ocular bleeding complications during vitreoretinal surgery. Medscape Medical News
Concert Laser Unmasks Eye Condition: EURETINA Case Reports
A laser reveals hidden vascular pathology, ocular findings signal cancer recurrence, and a possible link between eating disorders and retinal hemorrhage. Medscape Medical News
Early Pegcetacoplan Use Preserves More Retina in GA
Five-year data show pegcetacoplan slows geographic atrophy, with earlier treatment preserving more retinal tissue than delayed treatment. Medscape Medical News
Smartphone 3D Tool May Improve Ptosis Assessment
A smartphone-based 3D tool measures eyelid droop as accurately as specialists and may help clinicians decide which patients need surgery. Medscape Medical News
Retinal Thinning Seen Below Prediabetes A1c Threshold
Retinal neurodegenerative changes were associated with A1c levels below the current threshold for prediabetes, UK Biobank data show. Medscape Medical News
Conference MDAngle: AAO 2026 Wet Age-Related Macular Degeneration
Upcoming presentations on emerging wet AMD treatment strategies, including TKI, gene therapy, and personalized anti-VEGF therapy. Medscape